Table I.
Clinical characteristics of patients with and without sarcopenia.
| Variable | Sarcopenia | Non-sarcopenia | P-value |
|---|---|---|---|
| Mean age ± SD, years | 57.82±12.07 | 58.24±11.77 | 0.81 |
| Gender, n (%) | 0.02 | ||
| Male | 39 (40.63) | 2 (11.76) | |
| Female | 57 (59.38) | 15 (88.24) | |
| Body mass index, kg/m2 | 23.16±3.53 | 23.46±4.21 | 0.20 |
| Cancer stage, n (%) | 0.36 | ||
| Early stage (I–III) | 34 (35.42) | 8 (47.06) | |
| Advanced stage (IV) | 62 (64.58) | 9 (52.94) | |
| Surgical procedure, n (%) | 0.30 | ||
| No | 47 (48.96) | 6 (26.42) | |
| Yes | 49 (51.04) | 11 (35.29) | |
| Chemotherapy, n (%) | 0.72 | ||
| No | 19 (19.79) | 4 (23.53) | |
| Yes | 77 (80.21) | 13 (76.47) | |
| Radiotherapy, n (%) | 0.76 | ||
| No | 47 (48.96) | 9 (52.94) | |
| Yes | 49 (51.04) | 8 (47.06) | |
| Blood analysis, mean ± SD | |||
| Albumin, g/l | 36.71±4.65 | 39.67±3.69 | 0.11 |
| CD4, % | 30.47±4.74 | 32.71±5.75 | 0.92 |
| CD8, % | 22.97±4.74 | 23.00±2.74 | 0.07 |
| CD4/CD8, % | 1.44±0.29 | 1.38±0.37 | 0.54 |
| Lymphocytes, ~109m/l | 1.12±0.51 | 1.27±0.74 | 0.03 |
| Complications, n (%) | 0.57 | ||
| No | 73 (76.04) | 14 (82.35) | |
| Yes | 23 (23.96) | 3 (17.65) | |
| Eastern Cooperative Oncology Group score, n (%) | 0.19 | ||
| ≤1 | 78 (81.25) | 16 (94.12) | |
| >2 | 18 (18.75) | 1 (5.88) |
SD, standard deviation; CD, cluster of differentiation.